HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
TENT5A
terminal nucleotidyltransferase 5A
Chromosome 6 Β· 6q14.1
NCBI Gene: 55603Ensembl: ENSG00000112773.17HGNC: HGNC:18345UniProt: Q96IP4
45PubMed Papers
21Diseases
0Drugs
4Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
RNA bindingprotein bindingpoly(A) RNA polymerase activityregulation of ossificationcoronary artery diseaseosteogenesis imperfectaosteogenesis imperfecta, type 18Myocardial Ischemia
✦AI Summary

TENT5A is a cytoplasmic non-canonical poly(A) polymerase that catalyzes adenosine transfer to mRNA poly(A) tails, functioning as a critical regulator of bone formation and secretory protein expression 1. During osteoblast differentiation, TENT5A is induced and selectively polyadenylates mRNAs encoding extracellular matrix proteins, particularly type I collagen (Col1Ξ±1, Col1Ξ±2) and other ER-targeted secreted proteins, thereby increasing their expression and promoting bone mineralization 1. This specificity for ER-imported proteins is mediated by TENT5A localization at the endoplasmic reticulum membrane through interaction with transmembrane FNDC3 proteins 2. Homozygous mutations in TENT5A cause osteogenesis imperfecta type XVIII, a rare heritable skeletal dysplasia characterized by bone fragility and hypomineralization resulting from impaired collagen deposition by osteoblasts 3. TENT5A knockout mice display bone fragility and skeletal hypomineralization phenotypes due to quantitative and qualitative collagen defects, confirming its essential role in bone homeostasis 1. Beyond bone biology, TENT5A re-adenylates mRNA-1273 vaccine transcripts in immune cells, enhancing mRNA stability and vaccine efficacy 4, and regulates myogenic differentiation through myogenin stabilization 5. As a member of the TENT5 family of secretory tuners, TENT5A represents a novel class of posttranscriptional regulators with emerging roles in cancer, immunity, and other physiological processes 2.

Sources cited
1
TENT5A is a cytoplasmic poly(A) polymerase that polyadenylates mRNAs encoding Col1Ξ±1, Col1Ξ±2, and other secreted proteins during osteoblast differentiation; TENT5A KO mice display bone fragility and skeletal hypomineralization
PMID: 33882302
2
Homozygous mutations in TENT5A cause osteogenesis imperfecta type XVIII, a collagen-related disorder affecting bone mineralization and osteoblast differentiation
PMID: 39127989
3
TENT5A is a noncanonical poly(A) polymerase that selectively stabilizes mRNAs encoding ER-imported proteins; localized at ER membrane through FNDC3 interaction; member of TENT5 family of secretory tuners
PMID: 40407157
4
TENT5A re-adenylates mRNA-1273 vaccine transcripts in immune cells, extending poly(A) tails and stabilizing mRNAs; TENT5A deficiency reduces vaccine-specific immunoglobulin production in mice
PMID: 40240603
5
TENT5A regulates muscle fiber maturation by maintaining myogenin expression stability in myoblasts; differentially expressed in adolescent idiopathic scoliosis paravertebral muscle
PMID: 35137485
Disease Associationsβ“˜21
coronary artery diseaseOpen Targets
0.49Moderate
osteogenesis imperfectaOpen Targets
0.49Moderate
osteogenesis imperfecta, type 18Open Targets
0.48Moderate
Myocardial IschemiaOpen Targets
0.48Moderate
osteogenesis imperfecta type 3Open Targets
0.38Weak
Abnormality of refractionOpen Targets
0.34Weak
bone fractureOpen Targets
0.34Weak
radius fractureOpen Targets
0.34Weak
ulna fractureOpen Targets
0.34Weak
shoulder fractureOpen Targets
0.33Weak
coronary atherosclerosisOpen Targets
0.33Weak
Esophageal atresiaOpen Targets
0.30Weak
pyloric stenosisOpen Targets
0.30Weak
dyshidrosisOpen Targets
0.30Weak
breast carcinomaOpen Targets
0.29Weak
Abnormality of the skeletal systemOpen Targets
0.25Weak
Abnormality of skin pigmentationOpen Targets
0.25Weak
angina pectorisOpen Targets
0.21Weak
heart diseaseOpen Targets
0.21Weak
luminal A breast carcinomaOpen Targets
0.20Weak
Osteogenesis imperfecta 18UniProt
Pathogenic Variants4
NM_017633.3(TENT5A):c.65C>G (p.Pro22Arg)Likely pathogenic
Esophageal atresia;Pyloric stenosis
β˜†β˜†β˜†β˜†2019β†’ Residue 22
NM_017633.3(TENT5A):c.612_613dup (p.Ser205fs)Pathogenic
Osteogenesis imperfecta, type 18
β˜†β˜†β˜†β˜†2018β†’ Residue 205
NM_017633.3(TENT5A):c.380A>G (p.His127Arg)Pathogenic
Osteogenesis imperfecta, type 18
β˜†β˜†β˜†β˜†2018β†’ Residue 127
NM_017633.3(TENT5A):c.692A>G (p.Asp231Gly)Pathogenic
Osteogenesis imperfecta, type 18
β˜†β˜†β˜†β˜†2018β†’ Residue 231
View on ClinVar β†—
Related Genes
ELOVL4Protein interaction92%BCCIPProtein interaction81%ZHX3Shared pathway33%TENT5DShared pathway33%TAF15Shared pathway33%ATRAIDShared pathway29%
Tissue Expression6 tissues
Bone Marrow
100%
Heart
9%
Ovary
9%
Liver
5%
Lung
3%
Brain
2%
Gene Interaction Network
Click a node to explore
TENT5AELOVL4BCCIPZHX3TENT5DTAF15ATRAID
PROTEIN STRUCTURE
Preparing viewer…
PDB8EXF Β· 3.22 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.55Moderately Constrained
pLIβ“˜
0.93Intolerant
Observed/Expected LoF0.31 [0.19–0.55]
RankingsWhere TENT5A stands among ~20K protein-coding genes
  • #9,531of 20,598
    Most Researched45
  • #3,803of 5,498
    Most Pathogenic Variants4
  • #3,476of 17,882
    Most Constrained (LOEUF)0.55 Β· top quartile
Genes detectedTENT5A
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Update on the Genetics of Osteogenesis Imperfecta.
PMID: 39127989
Calcif Tissue Int Β· 2024
1.00
2
Re-adenylation by TENT5A enhances efficacy of SARS-CoV-2 mRNA vaccines.
PMID: 40240603
Nature Β· 2025
0.90
3
TENT5A mediates the cancer-inhibiting effects of EGR1 by suppressing the protein stability of RPL35 in hepatocellular carcinoma.
PMID: 39570560
Cell Oncol (Dordr) Β· 2024
0.80
4
TENT5/FAM46: An Enigmatic Family of Secretory Tuners.
PMID: 40407157
Traffic Β· 2025
0.70
5
Tent5a modulates muscle fiber formation in adolescent idiopathic scoliosis via maintenance of myogenin expression.
PMID: 35137485
Cell Prolif Β· 2022
0.60